Clinical trials of cost effectiveness in technology evaluation

Quarterly Journal of Nuclear Medicine

Volumn 44, Issue 2, 2000, Pages 197-203

  Valk, P E ^a  

^a NONE   (United States)

Author keywords

Clinical trials; Cost benefit analysis; Technology assessment, biomedical; Technology, medical

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MODEL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

BIAS (EPIDEMIOLOGY); CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DECISION TREES; DIAGNOSTIC IMAGING; HEALTH RESOURCES; HUMANS; LIFE EXPECTANCY; MODELS, THEORETICAL; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT CARE; PATIENT SELECTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TECHNOLOGY, RADIOLOGIC;

EID: 0033884828     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Evaluation of computed tomography: Achievement and challenge
2. The efficacy of diagnostic imaging
3. Outcomes research and cost-effectiveness analysis for diagnostic imaging
4. ROC methodology in radiologic imaging
5. Decision analysis
6. Randomized controlled trials are not appropriate for imaging technology evaluation
7. The importance of beta, the Type II error and sample size in the design and interpretaion of the randomized control trial: Survey of 71 'negative' trials
8. Guidelines for the clinical and economic evaluation of health care technologies
9. Increasing the scientific quality of clinical efficacy studies of magnetic resonance imaging
10. Assessment of radiologic tests: Control of bias and other design considerations
11. How to read journals. II. To learn about a diagnostic test
12. Sense and sensitivity: Issues in technology assessment (Editorial)
13. Whole-body PET imaging with F-18-fluorodexyglucose in management of recurrent colorectal cancer
14. Focusing technology assessment using medical decision theory
15. Uncertainty in the economic evaluation of health care technologies: The role of sensitivty analysis
16. Problems of using modelling in the economic evaluation of health care
17. Modelling in economic evaluation: An unavoidable fact of life